Lee Ainslie Lantheus Holdings, Inc. Transaction History

Maverick Capital LTD

  • $4.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$47.76 - $82.86 $81,096 - $140,696
1,698 Added 29.01%
7,551 $623,000
Q4 2022

Feb 14, 2023
BUY
$48.76 - $77.67 $123,362 - $196,505
2,530 Added 76.14%
5,853 $298,000
Q3 2022

Nov 14, 2022
BUY
$61.42 - $86.29 $204,098 - $286,741
3,323 New
3,323 $234,000

Others Institutions Holding LNTH

# of Institutions
539
Shares Held
69.9M
Call Options Held
651K
Put Options Held
459K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email